Thyroid Nodule

NEW YORK, Oct. 14, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leading developer and provider of microwave ablation ("MWA") medical devices in China, which recently expanded into the U.S. market following its U.S. FDA 510(k) clearances, today announced its participation in the upcoming American Thyroid Association (ATA) Annual Meeting. The event is scheduled to take place from October 30 to November 3, 2024, at the Sheraton Grand Chicago Riverwalk in Chicago, Illinois. Baird Medical will showcase its innovations at Booth 100, one of the largest exhibitor spaces at the event, featuring the Company's latest advancements in MWA technology and highlighting its impact on thyroid care. During the event, the Company will also host an Expo Theater Presentation on November 2, 2024, from 10:25 AM to 11:25 AM, inside the Exhibit Hall of the Chicago Ballroom. The session, titled "Latest Advancements in MWA for Thyroid Treatment," will provide valuable insights into recent developments in this field. It will feature Dr. Emad Kandil from Tulane University, Dr. Feng Than from Sun Yat-sen University, and Dr. Khadra Helmi from Houston Methodist Hospital. "We are excited to participate in the ATA Annual Meeting and present our innovations in microwave ablation technology," said Haimei Wu, Co-Founder of Baird Medical. "This event is an excellent opportunity to engage with leading experts and foster meaningful relationships to advance thyroid care. We warmly invite all attendees to visit our booth and attend our Expo Theater Presentation to explore our cutting-edge MWA technology." Baird Medical's participation in the event underscores its expansion into the U.S. market, following a successful listing on the Nasdaq exchange. The Company's recent FDA clearance for its minimally invasive microwave ablation technology offers a promising alternative to thyroidectomy for patients with benign thyroid tumors. With over 150,000 thyroidectomies performed annually in the U.S., Baird Medical's minimally invasive microwave ablation offers a safer, less invasive alternative for treating benign thyroid tumors. About the ATA® Annual Meeting The ATA® Annual Meeting is the world's preeminent event for those interested in thyroid diseases and disorders. It's an opportunity for peer-to-peer learning and collaboration through lectures, interactive discussions, meet the professor sessions, and abstracts. About Baird Medical Established in 2012 and headquartered in Guangzhou, China, Baird Medical is a leading microwave ablation ("MWA") medical device manufacturer and provider in China and a recent entrant to the United States market. Baird Medical's proprietary devices are used to treat both benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Baird Medical is the first company to obtain a Class III medical devices registration certificate for MWA medical devices specifically indicated for thyroid nodules in China. For more information, please visit . Contacts Investor Relations Robin Yang, Partner ICR, LLC Phone: +1 (646) 308-1475 Email: [email protected] Public Relations Brad Burgess, Senior Vice President ICR, LLC Phone: +1 (646) 588-0383 Email: [email protected] SOURCE Baird Medical Investment Holdings Ltd. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED

GUANGZHOU, China, Oct. 8, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China which has recently expanded into the U.S. market following its receipt of US FDA 510(k) clearances, today announced that the Company will participate in the following investor conference. Baird Medical's management plans to host one-on-one and small group meetings with institutional investors at the conference. Roth's 3rd Annual Healthcare Opportunities Conference Wednesday, October 9, 2024 Metropolitan Club, 1 E 60th Street, New York, NY, 10022 Baird Medical's participation in the event comes as the Company expands its footprint in the U.S. market following recent FDA clearance for its minimally invasive microwave ablation technology, which offers a promising alternative to thyroidectomy for patients with benign thyroid tumors. Currently, 150,000 thyroidectomies are performed in the U.S. annually. About Baird Medical Established in 2012 and headquartered in Guangzhou, China, Baird Medical is a leading microwave ablation ("MWA") medical device manufacturer and provider in China and a recent entrant to the United States market. Baird Medical's proprietary medical devices are used for the treatment of benign and malignant tumors including thyroid nodules, liver cancer, lung nodules and breast lumps. Baird Medical is the first company to obtain a Class III medical devices registration certificate for MWA medical devices specifically indicated for thyroid nodules in China. For more information, please visit . Contacts Investor Relations Robin Yang, Partner ICR, LLC Phone: +1 (646) 308-1475 Email: [email protected] Public Relations Brad Burgess, Senior Vice President ICR, LLC Phone: +1 (646) 588-0383 Email: [email protected] SOURCE Baird Medical Investment Holdings Ltd. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED

NEWNAN, Ga., Oct. 3, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Sabrina Rene, MD, FACE is acknowledged as a Pinnacle Professional Member for her contributions in Endocrinology. Continue Reading Sabrina Rene Dr. Sabrina Rene is a trailblazer in the field of endocrinology, dedicated to providing top-notch care to her local community. With a wealth of expertise in endocrine disorders and diabetes management, Dr. Rene has established herself as a trusted medical practitioner. She is a specialist in endocrinology, diabetes, PCOS, thyroid cancer, endocrine disrupting chemicals, thyroid ultrasound interpretations, and performing fine needle aspiration and biopsies of thyroid nodules. Armed with a Bachelor of Arts from New York University and a Doctor of Medicine from Howard University, Dr. Rene embarked on a journey of medical excellence. She further honed her skills through a rigorous residency at the prestigious Mayo Clinic, followed by a fellowship at Emory University, where she specialized in endocrinology. As a Fellow of the American College of Endocrinology (FACE) and a member of esteemed organizations such as the Endocrine Society; the National Medical Association (NMA); and the American Association of Clinical Endocrinologists, Dr. Rene remains at the forefront of advancements in her field. Board-certified in Endocrinology, diabetes, metabolism, and a certified expert in endocrine-disrupting chemicals, her dedication to continuing education ensures that she stays abreast of the latest developments and technologies in endocrinology. Touting more than 24 years of experience, Dr. Rene has been in private practice for five years, is co-owner of a group private practice for the last 10 years, and has been working in healthcare since 2018. Her extraordinary achievements have been punctuated with numerous awards and accolades including Top Doctors of America since 2018 and Best in Georgia magazine for endocrinology in April 2024. Beyond her professional commitments, Dr. Rene finds joy in traveling, especially to St. Lucia, and exploring new cultures, art, and music. She was also a member of the church choir. Her passion for holistic healthcare is reflected in her approach to patient care, where she considers not just the physical symptoms but also the overall well-being of her patients. The doctor said that her faith in God helps her to see the humanity and dignitiy in every patient. "This enables me to show compassion and empathy during difficult health crisis. I strive towards a thorough analysis of the endocrine condition coupled with education of the patient to understand their diagnosis," she explained. Dr. Rene's vision for the future includes conducting clinical research with a focus on endocrine-disrupting chemicals, aiming to shed light on their impact on human health. With a philosophy rooted in a holistic approach to medicine, she remains committed to providing comprehensive care to her patients, addressing both their medical needs and overall wellness. To her dear husband Andre, her parents, and brother, Dr. Rene expresses heartfelt gratitude for their unwavering love and support. She also thanks her many professional coaches, including Dr. Catherine Woodhouse, friends, and family for their encouragement throughout her journey which she notes has been instrumental in her pathway to success, and she looks forward to continuing to make a difference in the lives of her patients and community. Dr. Sabrina Rene's dedication to excellence and holistic healthcare sets her apart as a leader in the field of endocrinology, ensuring that her patients receive the highest quality of care and support. Contact: Katherine Green, 516-825-5634, [email protected] SOURCE The Inner Circle WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED